News

Thursday October 25, 2018

Directorate Change

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT […]

Wednesday October 24, 2018

UK government highlights global threat of AMR

Destiny Pharma plc (“Destiny Pharma” or the “Company”) Destiny Pharma’s lead asset, XF-73, well positioned to address the global threat of anti-microbial resistance highlighted in new UK government report Brighton, […]

Friday October 19, 2018

BIA celebrates UK bioscience innovative

Destiny Pharma plc (“Destiny Pharma” or the “Company”) BIA celebrates UK bioscience in creating innovative new drugs and treatment for patients A series of videos and explainer documents launched, focusing […]